Harry Jarrett | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Harry Jarrett | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Head of Science and Research at Heights, United Kingdom

Dr. Harry Jarrett is a passionate scientist with a focus on nutritional research, particularly in the context of chronic disease prevention. He believes that optimizing nutrition can significantly reduce the risk of prevalent health issues. With a PhD in Nutritional Sciences from Ulster University and a strong academic background, Dr. Jarrett has combined clinical and research expertise to contribute to the field of nutrition. His work spans various roles, including his current position as Head of Science and Research at Heights, where he leads human intervention trials and drives product development. Additionally, Dr. Jarrett has substantial experience in the medical field, including his work as a COVID-19 Research Laboratory Coordinator during the pandemic. His career is a testament to his commitment to advancing nutrition science and its real-world applications, striving to make significant contributions to improving public health through research and innovation.

Professional Profile

Education

Dr. Jarrett completed his PhD in Nutritional Sciences at the Nutrition Innovation Centre for Food and Health at Ulster University, where he focused on gene-environment interactions in blood pressure and stroke risk. His thesis investigated how riboflavin can lower systolic blood pressure, a significant finding in hypertension research. Prior to his PhD, he earned a Master’s degree in Exercise and Health Sciences from the University of Exeter, with a focus on nutrition’s impact on mental health and neurodegenerative diseases. Dr. Jarrett also completed a Bachelor’s degree in Exercise and Sport Sciences from the University of Exeter, graduating with first-class honors. His academic journey has been marked by strong achievements, including a postgraduate scholarship, distinction profile, and recognition for his contributions to research. Throughout his education, Dr. Jarrett has demonstrated a deep commitment to exploring the intersections between nutrition, health, and disease prevention.

Professional Experience

Dr. Jarrett’s professional experience spans several prestigious institutions and roles. Currently, he serves as Head of Science and Research at Heights, where he is responsible for the strategic direction and execution of research projects, including human intervention trials focused on nutrition and health. He also coordinates the translation of scientific findings into products and marketing strategies. From 2021 to 2024, Dr. Jarrett worked as a COVID-19 Research Laboratory Coordinator at Guy’s and St Thomas’ NHS Trust, where he managed clinical trials during the pandemic and was responsible for writing protocols, securing ethical approvals, and overseeing research quality. He also held a postdoctoral position at the NNEdPro Global Institute for Food and Nutrition Research, where he led investigations into cardiovascular disease risk factors using data from the UK Biobank. Additionally, Dr. Jarrett has contributed to academia by mentoring students and delivering lectures on nutrition and B-vitamin biochemistry.

Research Interests

Dr. Jarrett’s primary research interest lies in the relationship between nutrition and chronic disease prevention, with a particular focus on cardiovascular health and blood pressure regulation. His work has explored how micronutrients, especially B-vitamins like riboflavin, can impact blood pressure and metabolic function, offering new avenues for non-pharmacological interventions. His PhD research focused on understanding gene-environment interactions, specifically how certain genetic variations can influence an individual’s response to nutritional interventions. Dr. Jarrett is also interested in how nutrition can mitigate the effects of age-related diseases, including neurodegenerative conditions and mental health disorders. His ongoing research involves human intervention trials to assess the efficacy of nutritional supplements in improving health outcomes. Additionally, he is involved in investigating large datasets, such as those from the UK Biobank, to uncover insights into the broader epidemiological relationships between diet and health.

Awards and Honors

Dr. Harry Jarrett has received numerous accolades throughout his academic and professional career, reflecting his exceptional research contributions. Notably, he was awarded the Best Poster award at the Federation of American Societies for Experimental Biology (FASEB) conference for his work on folic acid and one-carbon metabolism. He also earned the Broadening Horizons Travel Bursary from Ulster University and a top-ranking young investigator abstract at the British and Irish Hypertension Society conference. Dr. Jarrett’s commitment to research excellence has earned him recognition from his peers and colleagues. His PhD research, published in the American Journal of Clinical Nutrition, has been widely cited and demonstrates his capacity to contribute to significant scientific advancements. Additionally, he has received honors such as the Postgraduate Commendation from the University of Exeter, further acknowledging his academic excellence and dedication to the field of nutrition science.

Conclusion

Dr. Harry Jarrett is a well-rounded and accomplished researcher with a clear impact in the field of nutrition science. His combination of robust academic background, hands-on clinical experience, leadership in research, and commitment to advancing public health makes him a highly suitable candidate for the Best Researcher Award. By enhancing his cross-disciplinary collaborations and expanding the visibility of his research, Dr. Jarrett has the potential to make even greater contributions to the field in the future.

Publications Top Noted

  • The Role of the Gut Microbiome and Probiotics in Sports Performance: A Narrative Review Update

    • Author(s): Harry Jarrett, Sophie Medlin, James C. Morehen
    • Year: 2025
    • Citation: Jarrett H, Medlin S, Morehen JC. The Role of the Gut Microbiome and Probiotics in Sports Performance: A Narrative Review Update. Nutrients. 2025;17(4):690. doi: 10.3390/nu17040690.
  • Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition

    • Author(s): Marlies Govaert, Chloë Rotsaert, Chelsea Vannieuwenhuyse, Cindy Duysburgh, Sophie Medlin, Massimo Marzorati, Harry Jarrett
    • Year: 2024
    • Citation: Govaert M, Rotsaert C, Vannieuwenhuyse C, Duysburgh C, Medlin S, Marzorati M, Jarrett H. Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition. Nutrients. 2024;16(8):2791. doi: 10.3390/nu16162791.
  • Magnesium in Human Health and Disease: A Review of Our Current Understanding

    • Author(s): Harry Jarrett, Ryan McNally, Anna Hernández-Rubio, Sally Brett, Luca Faconti
    • Year: 2024
    • Citation: Jarrett H, McNally R, Hernández-Rubio A, Brett S, Faconti L. Magnesium in Human Health and Disease: A Review of Our Current Understanding. EC Nutrition. 2024;23(7):2303-2315.
  • Association of dietary flavan-3-ol intakes with plasma phenyl-γ-valerolactones: analysis from the TUDA cohort of healthy older adults

    • Author(s): Donato Angelino, Aoife Caffrey, Helene McNulty, Chris IR. Gill, Pedro Mena, Alice Rosi, Katie Moore, Leane Hoey, Michelle Clements, Eamon Laird, et al.
    • Year: 2023
    • Citation: Angelino D, Caffrey A, McNulty H, Gill CIR, Mena P, Rosi A, Moore K, Hoey L, Clements M, Laird E, et al. Association of dietary flavan-3-ol intakes with plasma phenyl-γ-valerolactones: analysis from the TUDA cohort of healthy older adults. Am J Clin Nutr. 2023;118(2):426-438. doi: 10.1016/j.ajcnut.2023.06.006.
  • Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years

    • Author(s): Harry Jarrett, Helene McNulty, Catherine Hughes, Kristina Pentieva, James J. Strain, Anne Molloy, Aileen McCann, et al.
    • Year: 2022
    • Citation: Jarrett H, McNulty H, Hughes CF, Pentieva K, Strain JJ, Molloy A, McCann A, et al. Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years. Am J Clin Nutr. 2022;116(6):1422-1431. doi: 10.1093/ajcn/nqac240.
  • Validity of plasma phenyl-γ-valerolactones as novel biomarkers of dietary (poly)phenols: Preliminary analysis from the VALID project

    • Author(s): B. Parmenter, K. Moore, D. Angelino, D. Del Rio, H. McNulty, A.M. Molloy, C. Cunningham, M. Ward, B. Pucci, H. Jarrett, et al.
    • Year: 2018
    • Citation: Parmenter B, Moore K, Angelino D, Del Rio D, McNulty H, Molloy AM, Cunningham C, Ward M, Pucci B, Jarrett H, et al. Validity of plasma phenyl-γ-valerolactones as novel biomarkers of dietary (poly)phenols: Preliminary analysis from the VALID project. Proc Nutr Soc. 2018;77(3):234-243. doi: 10.1017/s0029665118001040.
  • Blood pressure and hypertension in relation to cognitive performance in older Irish adults from the TUDA cohort: Preliminary analysis

    • Author(s): Harry Jarrett
    • Year: 2018
    • Citation: Jarrett H. Blood pressure and hypertension in relation to cognitive performance in older Irish adults from the TUDA cohort: Preliminary analysis. J Hum Hypertens. 2018;32(5):319-326. doi: 10.1038/s41371-018-0089-5.
  • Effect of B-vitamin Supplementation on Cognitive Performance and Brain Function in The BrainHOP Trial

    • Author(s): Katie Moore, Catherine Hughes, Kirsty Porter, Leanne Doherty, Pramod Gaur, Fergal Tracey, Maurice O’Kane, Harry Jarrett, Mary Ward, Leanne Hoey
    • Year: 2018
    • Citation: Moore K, Hughes C, Porter K, Doherty L, Gaur P, Tracey F, O’Kane M, Jarrett H, Ward M, Hoey L. Effect of B-vitamin Supplementation on Cognitive Performance and Brain Function in The BrainHOP Trial. Age Ageing. 2018;47(5):702-710. doi: 10.1093/ageing/afy141.35.

 

MD REYAD UL FERDOUS | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. MD REYAD UL FERDOUS | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

postdoctoral at Tsinghua University, China

Md. Reyad-ul-Ferdous is a dedicated researcher specializing in endocrinology, metabolism, and pharmaceutical sciences. With extensive experience in drug discovery and metabolic disease research, he has made significant contributions to the study of mitochondrial function, obesity-related diseases, and liver disorders. His academic and professional journey spans multiple prestigious institutions, including the Chinese Academy of Sciences, Tsinghua University, and Shandong University. Over the years, he has published in peer-reviewed journals, contributed to book chapters, and led innovative research in pharmaceutical technology. His expertise covers a broad spectrum, including natural product chemistry, bioinformatics, CRISPR-Cas9, and metabolic disease modeling. With a strong commitment to scientific advancement, he actively participates in global collaborations, striving to develop novel therapeutic solutions.

Professional Profile

Education

Md. Reyad-ul-Ferdous earned his Ph.D. in Biochemistry and Molecular Biology from the Chinese Academy of Sciences, focusing on drug molecules modulating UCP1 expression in adipocytes. Before that, he completed an M. Pharm in Pharmaceutical Technology and Biopharmaceutics from North South University, Bangladesh, where he researched oral thin film formulations. His B. Pharm in Pharmacy from State University of Bangladesh laid the foundation for his pharmaceutical expertise, with research on phytochemical screenings. Additionally, he pursued online certifications from University of California, San Francisco; University of Maryland; and Vanderbilt University to enhance his knowledge in diabetes, genetics, and personalized medicine. His strong academic background, combined with advanced training in pharmaceutical sciences, has equipped him with a diverse skill set in drug discovery, metabolic research, and clinical applications.

Professional Experience

Currently, Md. Reyad-ul-Ferdous is a Postdoctoral Research Scientist at Tsinghua University’s Institute of Biopharmaceutical and Health Engineering, where he investigates obesity-related disorders and drug formulations. Previously, he worked as a Postdoctoral Researcher at Shandong University, focusing on lipid metabolism, mitochondrial function, and non-alcoholic fatty liver disease (NAFLD/NASH). His early career included serving as a Lecturer in Pharmacy at Shamoli Ideal Medical Institute and Progati Medical Institute in Bangladesh, where he contributed to pharmaceutical education. Throughout his professional journey, he has worked on multiple national and international research projects, collaborating with top-tier institutions to develop therapeutic interventions. His hands-on expertise in drug screening, disease modeling, and pharmacological research has positioned him as a valuable contributor to the global scientific community.

Research Interests

Md. Reyad-ul-Ferdous focuses on metabolic diseases, mitochondrial function, and drug discovery. His primary interest lies in browning white adipose tissue to combat obesity and developing novel therapeutics for NAFLD, NASH, and liver diseases. He is also exploring the gut microbiota’s role in liver diseases, aiming to develop targeted treatments for metabolic disorders. With expertise in pharmaceutical formulations and natural product pharmacology, he investigates bioactive compounds, antioxidants, and flavonoids as potential therapeutic agents. His multidisciplinary approach includes CRISPR-Cas9, cell culture, bioinformatics, and pharmacogenomics, making his research highly relevant to personalized medicine. By integrating biochemistry, molecular biology, and pharmaceutical sciences, he aims to develop innovative treatments for obesity-related diseases, metabolic dysfunctions, and liver fibrosis.

Awards and Honors

Md. Reyad-ul-Ferdous has received multiple prestigious awards and scholarships in recognition of his scientific contributions. He was awarded the CAS-TWAS President Fellowship Program, the Chinese Scholarship Council (CSC) Scholarship, and the Postdoctoral Research Grants from the National Natural Science Foundation of China. He has also been honored as a Lead Guest Editor for scientific journals such as the American Journal of Clinical and Experimental Medicine and the American Journal of BioScience. Additionally, he participated in the 2019 ANSO Young Scientists Forum and Zhejiang International Science and Technology Cooperation Conference, further establishing his global research presence. His numerous grants and research fellowships highlight his dedication to advancing pharmaceutical and metabolic disease research.

Conclusion

Md. Reyad-ul-Ferdous is a highly qualified researcher with strong academic credentials, significant postdoctoral experience, and expertise in metabolic disease research. His contributions to pharmaceutical sciences, obesity-related drug discovery, and mitochondrial function research make him a strong contender for the Best Researcher Award.

Publications Top Noted

  • Title: Present biological status of potential medicinal plant of Amaranthus viridis: a comprehensive review
    Author: M Reyad-ul-Ferdous, DS Shahjahan, S Tanvir, M Mukti
    Year: 2015
    Cited by: 75

  • Title: Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue
    Author: Y Qiu, Y Sun, D Xu, Y Yang, X Liu, Y Wei, Y Chen, Z Feng, S Li, …
    Year: 2018
    Cited by: 44

  • Title: Biologically potential for pharmacologicals and phytochemicals of medicinal plants of Colocasia esculenta: A comprehensive review
    Author: M Reyad-ul-Ferdous, MSI Arman, MMI Tanvir, S Sumi, K Siddique, …
    Year: 2015
    Cited by: 32

  • Title: Significant effect of NSP-ase enzyme supplementation in sunflower meal-based diet on the growth and nutrient digestibility in broilers
    Author: M Bilal, MA Mirza, M Kaleem, M Saeed, M Reyad-ul-Ferdous, …
    Year: 2017
    Cited by: 21

  • Title: Ex-Vivo anti-inflammatory and antimicrobial activities of the leaves of Bauhinia acuminata
    Author: M Reyad-Ul-Ferdous, MZIK Sayma Akhter, ME Khan, MA Islam, MS Ullah
    Year: 2014
    Cited by: 20

  • Title: Ex-vivo cardioprotective and cytotoxic screening of fruits of Parmentiera cereifera seem
    Author: M Reyad-ul-Ferdous, TT Alam, MA Islam, MZI Khan, F Tasnim, ME Khan, …
    Year: 2014
    Cited by: 18

  • Title: Inhibition of insulin degrading enzyme to control diabetes mellitus and its applications on some other chronic disease: A critical review
    Author: MS Azam, M Wahiduzzaman, M Reyad-ul-Ferdous, MN Islam, M Roy
    Year: 2022
    Cited by: 17

  • Title: Investigation of the medicinal potentials of Syzygium jambos (L.) extract and characterization of the isolated compounds
    Author: M Haque, MM Begum, M Hasan, AFMT Rahman, MI Hussain, …
    Year: 2015
    Cited by: 15

  • Title: Berberine chloride (dual topoisomerase I and II inhibitor) modulate mitochondrial uncoupling protein (UCP1) in molecular docking and dynamic with in-vitro cytotoxic and …
    Author: MR Ferdous, M Abdalla, M Yang, L Xiaoling, Y Song
    Year: 2023
    Cited by: 14

  • Title: Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation
    Author: X Li, M Yang, H Sun, MR ul Ferdous, L Gao, J Zhao, Y Song
    Year: 2022
    Cited by: 14

  • Title: Baicalein modulates mitochondrial function by upregulating mitochondrial uncoupling protein-1 (UCP1) expression in brown adipocytes, cytotoxicity, and computational studies
    Author: M Reyad-ul-Ferdous, Y Song
    Year: 2022
    Cited by: 12

  • Title: Glycyrrhizin (Glycyrrhizic Acid) HMGB1 (high mobility group box 1) inhibitor upregulate mitochondrial function in adipocyte, cell viability and in-silico study
    Author: M Reyad-ul-Ferdous, M Abdalla, Y Song
    Year: 2022
    Cited by: 12

  • Title: Preliminary in vitro biological and phytochemical screenings of Parmentiera cereifera Seem
    Author: M Reyad-ul-Ferdous, RB Rashid, MAA Sikder, F Aktar, MA Rashid
    Year: 2012
    Cited by: 12

  • Title: Phytochemical screening, in-vitro membrane stabilizing and thrombo-lytic activities of Lophopetalum javanicum
    Author: M Reyad-ul-Ferdous, MG Azam, MD Hossain
    Year: 2014
    Cited by: 10

  • Title: Evaluation of antioxidant, analgesic and antidiarrheal activities of methanolic extract of Litsea monopetala (roxb.) leaves
    Author: MR Ferdous, M Ashrafudolla, MS Hossain, SF Bellah
    Year: 2018
    Cited by: 9

  • Title: Evaluation of Ex-Vivo Anti-inflammatory and total phenolic content of fruits of Parmentiera cereifera seem
    Author: M Reyad-ul-Ferdous, MI Hussain, M Mukti, MA Islam, MN Islam, …
    Year: 2015
    Cited by: 9

  • Title: Screening of Antioxidant and Antimicrobial Properties of the Syzygium jambos L.
    Author: MM Begum, M Haque, M Reyad-ul-Ferdous, M Hasan, H Tarek, …
    Year: 2015
    Cited by: 8

  • Title: Epigenetic drug (XL019) JAK2 inhibitor increases mitochondrial function in brown adipocytes by upregulating mitochondrial uncoupling protein 1 (UCP1), screening of epigenetic …
    Author: M Reyad-ul-Ferdous, M Abdalla, M Yang, L Xiaoling, W Bian, J Xie, …
    Year: 2022
    Cited by: 7

  • Title: Roundness and taper of holes during drilling composites of various thickness by HSS drill bit under dry condition
    Author: MS Sakib, M Rahman, M Ferdous, NR Dhar
    Year: 2017
    Cited by: 7

  • Title: Evaluation of Potential Antioxidant Activity of Leaves of Bauhinia Acuminate: Evaluation of Potential Antioxidant Activity of Leaves
    Author: M Reyad-ul-Ferdous, F Liza, TT Alam, F Tasnim, M Mukti, ME Khan, …
    Year: 2014
    Cited by: 7